NCT04252651

Brief Summary

This study will involve blood draws to test for specific cytokines. The study goal is to gain a better understanding of the role of inflammatory response in the development of specific complications in burn and TENS patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 25, 2021

Status Verified

August 1, 2021

Enrollment Period

3 years

First QC Date

January 28, 2020

Last Update Submit

August 24, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cytokine Response that develops into complications

    The number of burn and TENS patients that develop subsequent medical complications

    up to one year

Study Arms (1)

Blood Draw

This study will involve blood draws to test for specific cytokines

Other: Blood Draw

Interventions

This study will involve blood draws to test for specific cytokines

Blood Draw

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Samples size will be patients from the burn ICU.

You may qualify if:

  • is ≥18 years of age
  • has been admitted to the Joseph M. Still Burn Center at Doctors Hospital Augusta with a burn diagnosis, or TENS OR SJS diagnosis (confirmed or non-confirmed), with an expected length of stay to be at least 7 days
  • the subject or their legally authorized representative is able to provide informed consent
  • has a negative urine or serum pregnancy test at screening (if female and has potential for pregnancy)

You may not qualify if:

  • is moribund, or in the opinion of the investigator is not expected to survive
  • has sustained an electrical burn

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joseph M. Still Burn Center at Doctors Hospital

Augusta, Georgia, 30909, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Multiple Organ FailureCross InfectionVenous Thrombosis

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

ShockPathologic ProcessesPathological Conditions, Signs and SymptomsInfectionsIatrogenic DiseaseDisease AttributesThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Michael Quinn, MD

    Joseph M. Still Research Foundation, Inc.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2020

First Posted

February 5, 2020

Study Start

October 2, 2019

Primary Completion

October 1, 2022

Study Completion

December 1, 2022

Last Updated

August 25, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will share

Study results will be analyzed, and study data presented at an appropriate related Congress meeting. Journal publication in a related peer-reviewed journal would be expected after presentation.

Locations